60 results
CORRESP
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
29 Oct 20
Correspondence with SEC
12:00am
be no assurance they will continue to use CleanCap® through commercialization.
Pages 6, 134 and 141
Six of the 25, including one phase II/III clinical … products. Given the early stage of these three programs, there can be no assurance they will continue to use CleanCap® through commercialization
S-1/A
EX-1.1
2z7 trlambs6
9 Nov 20
IPO registration (amended)
2:05pm
S-8
EX-5.1
i9n vb54y
23 Nov 20
Registration of securities for employees
5:06pm